Baron Rubahamya

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Body Mass Index

Diffusion Weighted Imaging

Top Venues

Science advances

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Baron Rubahamya, Shujun Dong, Greg M Thurber
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data. Science advances 10 (22) (2024)
Baron Rubahamya, Shujun Dong, Greg M Thurber
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data. Science advances 10 (22) (2024)
Baron Rubahamya, Shujun Dong, Greg M Thurber
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data. Science advances 10 (22) (2024)
Baron Rubahamya, Shujun Dong, Greg M Thurber
Clinical translation of antibody drug conjugate dosing in solid tumors from preclinical mouse data. Science advances 10 (22) (2024)
Ian Nessler, Baron Rubahamya, Anna Kopp, Scott Hofsess, Thomas M Cardillo, Nalini Sathyanarayan, Jennifer Donnell, Serengulam V Govindan, Greg M Thurber
Improving Intracellular Delivery of an Antibody-Drug Conjugate Targeting Carcinoembryonic Antigen Increases Efficacy at Clinically Relevant Doses In Vivo. Molecular cancer therapeutics (2023)